INTRODUCTION
Protein kinase A (PKA) activators such as cholera toxin (CT) and isobutyl methylxanthine (IBMX) are potent regulators of breast cell growth in vivo and in vitro [1] . In estrogen receptor (ER)-containing breast cancer cells, we and others have shown that PKA activators enhance the transcription of estrogen regulated genes such as pS2, cathepsin D or progesterone receptor [2] [3] [4] and that this effect is blocked by the pure antiestrogen ICI 164,384 [2, 4] . These results are also observed in transient transfection experiments, with the magnitude of transcriptional enhancement dependent on the cellular context and gene construct used [5] [6] [7] [8] [9] . For example, in some cell types, PKA can act synergistically with the estradiol (E 2 )-occupied ER to activate transcription of estrogen response element (ERE)-containing reporter gene constructs [9] . Of particular interest is the observation that PKA activators can alter the agonist/antagonist balance of antiestrogens, conferring some agonistic activity to antiestrogens such as trans-hydroxytamoxifen (TOT) in cells in which TOT normally behaves as a pure antagonist. In addition, PKA activators reduced the inhibitory effectiveness of TOT in repressing E 2 -ER mediated transcription [8, 10] . PKA activators can also transform some dominant negative ER mutants into transcriptional activators in the presence of either E 2 or antiestrogens [9] .
In the classical and most simple model of action of nuclear receptors [11] , the receptor is activated by its cognate ligand [12, 13] and binds to its specific hormone response element on its target genes. The magnitude of transcriptional activity is modulated by coactivator complexes [14, 15] and proceeds by interaction with chromatin and the pre-initiation complex [15] [16] [17] . Interaction between estrogen signaling and other nuclear receptors [18, 19] , protein kinase C [20] , general transcription factors [21] [22] [23] and/or MAP kinase [24, 25] is documented, but little is known about the mechanism underlying estrogen/PKA cross-talk.
The interaction between PKA activators and ER is of particular interest since the treatment of ER-positive breast tumors often utilizes antiestrogens. In cases where PKA is unregulated and especially active, antiestrogen therapy might prove ineffective. In fact, in ER-positive breast HAL author manuscript inserm-00143971, version 1
Lazennec et al. September 11, 2000 4 cancers, only in two-third of the cases is antiestrogen treatment effective [26] [27] [28] . Hence, in certain circumstances, PKA activity might be involved in antiestrogen insensitivity as well as in the development of tamoxifen resistance. Therefore, the aim of this study is to elucidate the molecular mechanisms involved in estrogen/PKA activator synergy. Based on the observations that PKA activators can modulate the activity and also the phosphorylation state of ER [5, 29] , and that E 2 can increase intracellular cAMP levels in some cells [30, 31] , we focused on the cross-talk between these two pathways.
In this study, we investigated E 2 -ER/PKA synergy using two cell lines, CHO cells, which displayed ER transcriptional synergy with E 2 and PKA, and SK-BR-3 cells, which did not exhibit this E 2 -ER/PKA transcriptional synergy. Because CREB is activated by PKA [32, 33] and since CBP (CREB binding protein) is a coactivator for both CREB and ER [34] [35] [36] , we examined whether CREB was involved in the synergistic activation of ER by E 2 and PKA. We found that CREB could enhance the activity of ER in CHO cells, and that when CREB was transfected into SK-BR-3 cells, we saw transcriptional synergy where this was not seen if CREB was not transfected into these cells. These data suggest that part of the cross-talk between ER and PKA pathways involves CREB, and we propose a model to explain this whereby CREB is tethered to DNA by the ER-coactivator complex and can therefore increase transcriptional activity, even on genes lacking a cyclic AMP response element (CRE). This hypothesis has implications for the regulation of estrogen-responsive genes by estrogen and antiestrogen in breast cancer and other ER-containing cells, especially if PKA is up-regulated or overexpressed in these cells. 
MATERIALS AND METHODS

Plasmids and General Reagents
Estradiol 17β(E 2 ), cholera toxin (CT) and isobutyl methylxanthine (IBMX) were purchased from Sigma. Restriction enzymes were purchased from Life Technologies, Inc. and New England
Biolabs. The plasmids 2ERE-pS2-CAT [37] and pCH110 [5] have been previously described. (lose restriction site, HindIII). The mutation S518A was previously described in Ekena et al. [40] .
Oligonucleotides were purchased from Life Technologies, Inc. Screening for desired mutations was done by restriction analysis. Following mutagenesis, the ER cDNA clones were excised from pBluescript II SK + using BamHI and ligated into the BamHI site of pCMV5, kindly provided by precipitated DNA for 4 h and then subjected to a 1.5 min glycerol shock using 20% glycerol in
Hanks' balanced salt solution (HBSS) followed by 1 min in HBSS. Fresh medium and ligands were then added. Cells were harvested 24 h after ligand treatment and lysed by three cycles of freezing on dry ice and thawing at 37 0 C. ER transactivation activity was determined by CAT activity of the whole cell lysates and assayed as described previously [42] . CAT activity was normalized for transfection efficiency using the cotransfected internal control pCH110 β-galactosidase activity plasmid.
Preparation of Nuclear Extracts
Cells were harvested, washed in phosphate buffered saline (PBS), and resuspended in hypotonic buffer (10 mM HEPES pH 5.9, 10 mM KCl, 0.1mM EDTA, 0.1mM EGTA, 1mM 
Gel Mobility Shift Assays
Gel mobility shift assays were carried out as previously described [43] . Briefly 30,000 cpm of the 32 P-labeled oligonucleotide was combined with 6 µg of nuclear protein and 1 µg poly (dI-dC) (Sigma, St. Louis, MO) in a buffer containing 20 mM HEPES, pH 7.9; 1 mM DTT; 50 mM KCl; 10% glycerol; 2. 
RESULTS
Site-directed mutagenesis of cAMP-dependent protein kinase phosphorylation sites in the human estrogen receptor
The human ERα (hERα) is known to be a phosphoprotein, and enhanced phosphorylation occurs on serine residues upon treatment with hormone or protein kinase A (PKA) activators [29, 44] . Examination of the amino acid sequence of hERα, revealed that there were four potential sites of phosphorylation by PKA (S236, S305, S338, S518). Serine 236 is in the DNA binding domain (C domain, residues 180-263), with S305, S338 and S518 being in the hormone binding domain (E domain, residues 303-553). These serines are in cAMP-dependent protein kinase phosphorylation sequences XRRXSX or SKKXSX.
These serines were mutated to alanine either separately, or in some cases together, to determine whether the synergistic enhancement of transcription by estradiol and the PKC activator cholera toxin/IBMX was dependent on these residues. The mutant receptors were transiently transfected into Chinese hamster ovary (CHO) cells along with an estrogen-responsive 2ERE-pS2-CAT reporter, which contains two consensus EREs upstream of the promoter from pS2, which is an estrogen regulated gene. As can be seen in Figure 1 , none of these mutations had an effect on receptor transcriptional activity. All of the mutants showed response to estradiol (10 -10 M) of a magnitude similar to that of the wild type (wt) ER, and all showed enhancement of transcriptional activity in the presence of E 2 and PKA activator. Even when the serine at 338 was mutated to a glutamate (S338E) to mimic the acidic charge of a phospho group, activity similar to wild type ER was observed. These findings indicate that phosphorylation at these sites is not essential for the estradiol/PKA activator synergy observed in these cells.
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CHO cells and SK-BR-3 cells respond in a different manner to PKA activators
Based on the lack of effect of the phosphorylation site ER mutagenesis experiments, we hypothesized that other proteins activated by PKA might be involved in the E 2 /PKA transcriptional synergy. We examined the role of CREB, not only because it is activated by PKA, but because it shares a common coactivator with the ER [36] . To this end, we constructed several different reporter constructs with the pS2 minimal promoter and controlled by EREs or CREs, either alone or together. These reporter constructs were tested in CHO cells and in SK-BR-3 breast cancer cells, both of which are ER-negative cells.
In CHO cells ( Fig. 2A) , activity on the 2ERE-pS2-CAT reporter was dependent on the presence of transfected ER and the response to E 2 + CT/IBMX was markedly greater than that in the presence of E 2 alone. The cAMP response element (CRE) activity (CRE-pS2-CAT) was stimulated by CT/IBMX in the absence or presence of transfected ER, but this activity was higher with cotransfection of ER. CRE activity in the presence of CT/IBMX was not enhanced with E 2 + CT/IBMX stimulation and both were about 3-fold higher than the stimulation in the absence of ER.
This may reflect the finding that CREB phosphorylation can be regulated by E 2 [45] . As would be predicted, the reporter 2(ERE-CRE)-pS2-CAT displayed higher activity than either CRE or ERE construct alone. ER increased the response seen on all three reporter constructs; however, the CRE was still only inducible by CT/IBMX. The transcriptional synergy between E 2 and CT/IBMX was seen on both the 2ERE-pS2-CAT and 2(ERE-CRE)-pS2-CAT reporter genes.
In SK-BR-3 cells (Fig. 2B) , a different pattern of response was observed. The CRE construct was inactive even when cells were treated with CT/IBMX and this activity changed little with the addition of ER to the cells. A transcriptional synergy was observed on the 2(ERE-CRE)-pS2-CAT reporter, as in the CHO cells. However, no synergy was seen on the 2ERE-pS2-CAT
reporter, unlike what is seen in CHO cells. Therefore, we decided that since these two cell lines displayed differences in the estradiol/PKA activator transcriptional synergy on the ERE-containing HAL author manuscript inserm-00143971, version 1 reporter gene, they would be worthwhile to use in examining the phenomenon of transcriptional synergy.
Assessment of the involvement of CREB in ER transcriptional activity
To determine if CREB was involved in the different responses observed in CHO and SK-BR-3 cells, we transfected a human CREB expression plasmid into these cells. In CHO cells (Fig.   3 ), CREB enhanced the transcriptional response evoked by E 2 + CT/IBMX on the three different gene constructs. The enhancement by CREB was dramatic on all 3 constructs. The stimulation was reduced at the highest level of transfected CREB, presumably due to squelching, but it was still higher than without CREB (empty CMV5 vector). In contrast, a dominant negative mutant of CREB called KCREB, for Killer CREB [46] , was much less effective and did not achieve the levels of induction seen with wild type CREB.
When CREB was expressed in SK-BR-3 cells (Fig. 4) , a very interesting result was observed. On the 2ERE-pS2-CAT reporter, where synergy was not observed with E 2 and CT/IBMX with ER alone (cf. Fig. 2B ), addition of CREB now resulted in transcriptional synergy between E 2 and CT/IBMX. On the 2(ERE-CRE)-pS2-CAT reporter, where synergy was observed with E 2 plus CT/IBMX with ER alone (cf. Fig. 2B ), synergistic activity was still observed with ER and added CREB but the levels of CAT activity were somewhat reduced upon addition of CREB. This may be due to the fact that activation without added CREB was already about at the maximum because of saturation of essential coactivators.
Examination of CREB isoforms present in CHO cells and SK-BR-3 cells
Because of the differences in activation on CREs in CHO cells and SK-BR-3 cells, gel shift experiments were performed using nuclear extracts from both cell lines. In CHO cells (Fig. 5A) , the major isoforms of CREB present that bound to a radiolabeled CRE oligo probe were CREB1 and CREM1. This was also the case in SK-BR-3 cells (Fig. 5B) . Interestingly, in the SK-BR-3
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11 cells, a lower band was also seen, but this could not be shifted with CREB antibodies. Thus the expression of CREB isoforms in both cell lines appeared to be similar and did not appear to account for the differences in transcriptional activity seen on the CRE-pS2-CAT reporter.
CREB interacts with ER on an ERE
Because transfected CREB could enhance transcription in both cell lines as well as restore synergistic transcription on the 2ERE reporter in SK-BR-3 cells, we examined whether ER and CREB could interact. We could not detect any interaction between these proteins in immunoprecipitation experiments (data not shown). Neither could we detect any interaction in gel super-shift assays using ER and CREB antibodies and radiolabeled CRE or ERE oligomers (data not shown). Since these assays would be unlikely to detect indirect or weak interactions, we performed experiments using a modified mammalian two-hybrid system in intact cells, where full length ER was used to bind to a 1ERE-pS2-CAT reporter and various CREB-VP16 constructs were tested (Fig. 6 ). As can be seen in this experiment, full length wild type CREB could interact with the ER on this reporter (ER plus VP16:CREB). Note that this gene construct, containing only 1 ERE, does not show any estradiol mediated activation of the estrogen receptor (ER + VP-16).
By contrast, KCREB, a dominant negative version of CREB that is deficient in DNA binding [46] , did not show any interaction in this protein interaction system.
DISCUSSION
Transcriptional synergy between ER and PKA activators on ERE regulated genes is well documented in both long-term cultured cells and primary cultured estrogen target cells [5] [6] [7] [8] . Our experiments reveal that the protein CREB is involved in this synergy. Although the ER is a phosphoprotein [29, 30] , our data suggest that it may not be directly phosphorylated by PKA since elimination of potential PKA phosphorylation sites did not reduce the transcriptional activity of ER in response to E 2 and PKA activators. Because it was possible that PKA was activating other proteins that interacted with the ER, we examined the role of CREB, a protein known to be phosphorylated by PKA [4, 47, 48] , which also shares a common coactivator with ER, namely CBP [34, 35] .
CREB is a transcription factor that binds to a CRE, which consists of the motif, 5'-TGACGTCA-3' (for review [49] ). Numerous CREB-related proteins have been identified including CREB-1, CREB-2, ATF-1, ATF-2, ATF-3, ATF-4 and CREM1 [49] . CREB is part of the family of bZIP transcription factors, which have a basic activation region and a leucine zipper dimerization domain [49] . In the amino terminal region of CREB is a region called KID (kinase inducible domain) or P box. This contains a large proportion of acidic residues [29, 47, 50] , as well as a serine at position 133 which is the target of PKA [47] . This phosphorylation is thought to alter the conformation of the transactivation domain which presents the glutamine rich regions for interaction with the pre-initiation complex [51] . CREB is able to dimerize with CREM or ATF-1, but there is also possible heterodimerization of ATF members with c-fos, c-jun or C/EBP [29, 52] . It has been shown that CREB could act synergistically with nuclear receptors such as SF-1 [53] .
To examine the possibility of CREB and ER interaction, we used two cell lines which displayed different responses to PKA activators and estrogen: CHO cells, which exhibited transcriptional synergy, and SK-BR-3 cells, which did not exhibit the synergy. We also used several different reporter constructs that had EREs exclusively or a combination of EREs and HAL author manuscript inserm-00143971, version 1
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Transfection of CREB expression vector into CHO cells enhanced the transcriptional activity of ER on gene constructs containing only a CRE, or only EREs, or combined CREs and EREs (Fig. 3) . Most interestingly, in SK-BR-3 cells transcriptional synergy on the 2ERE reporter was observed only when additional CREB was provided to the cells. In contrast, in SK-BR-3 cells, the reporter containing combined CREs and EREs did show transcriptional synergy, even without transfected CREB, which was expected since endogenous CREB can bind directly to the CRE DNA. This supports the contention that the mechanism of transcriptional synergy is different on the ERE versus the combined CRE-ERE constructs examined. Although the response of CHO and SK-BR-3 cells was different with respect to CT/IBMX, we could not detect any differences in the expression of endogenous CREB proteins to account for the differences in transcriptional response as both cell types appeared to express the same isoforms of CREB.
We tried to test for a direct interaction between ER and CREB using several different techniques for detecting protein-protein interactions, but it was only in the in vivo mammalian interaction assay that we observed interaction. This leads us to believe that the interaction is not direct, but is mediated by coactivator proteins such as CBP and SRC-1 or other SRC family members. SRC-1 is a steroid receptor coactivator and CBP is a common coactivator for both ER and CREB. It has been shown that CBP and SRC-1 interaction results in synergistic enhancement of ER transcriptional activity upon estradiol occupancy of the receptor [54, 55] . experiments is a transcriptional synergy on reporter genes containing only EREs where CREB cannot bind to these DNA sites. Thus we hypothesize that CREB can be recruited to the ERcoactivator complex by being tethered via ER and certain coactivators such as CBP (Fig. 7) . This would result in greater transcription of the gene, even though CREB does not bind to the ERE DNA directly. Such a mechanism is documented in a reciprocal sense for activation of AP-1 enhancer elements by ER, where the ER does not bind the DNA [21] . To test this hypothesis, a dominant negative mutant form of CREB, KCREB, was tested in the mammalian cell protein interaction system, and the KCREB did not show any interaction with ER.
In the model presented in Based on the mammalian protein interaction assay and the lack of interaction in GST pulldowns and gel-shift assays, it is likely that the interaction of CREB and ER is indirect, mediated through other coactivator proteins such as SRC-1 and CBP. CBP is a coactivator for both CREB and ER, and these domains of interaction are distinct, which would allow for both transcription factors to bind. In addition, the coactivator SRC-1 binds both ER and CBP, so it could also be involved in the interaction. Our model proposes that CREB is being recruited to the ERE by the ER-SRC-CBP complex, which means that CREB does not need to bind the DNA to modulate the transcriptional activity. This is the reverse of the case in the activation of the ovalbumin gene by ER through the AP-1 activator complex, where ER does not bind DNA [27] .
In our observations, the coactivators serve as adaptors connecting two distinct activators which HAL author manuscript inserm-00143971, version 1
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